JP2024507550A5 - - Google Patents

Info

Publication number
JP2024507550A5
JP2024507550A5 JP2023550695A JP2023550695A JP2024507550A5 JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5 JP 2023550695 A JP2023550695 A JP 2023550695A JP 2023550695 A JP2023550695 A JP 2023550695A JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound according
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023550695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507550A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/017134 external-priority patent/WO2022182604A1/en
Publication of JP2024507550A publication Critical patent/JP2024507550A/ja
Publication of JP2024507550A5 publication Critical patent/JP2024507550A5/ja
Withdrawn legal-status Critical Current

Links

JP2023550695A 2021-02-23 2022-02-21 Hiv療法に有用な化合物 Withdrawn JP2024507550A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163152356P 2021-02-23 2021-02-23
US63/152,356 2021-02-23
PCT/US2022/017134 WO2022182604A1 (en) 2021-02-23 2022-02-21 Compounds useful in hiv treatment

Publications (2)

Publication Number Publication Date
JP2024507550A JP2024507550A (ja) 2024-02-20
JP2024507550A5 true JP2024507550A5 (cg-RX-API-DMAC7.html) 2025-03-05

Family

ID=80685329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550695A Withdrawn JP2024507550A (ja) 2021-02-23 2022-02-21 Hiv療法に有用な化合物

Country Status (4)

Country Link
US (1) US20240182510A1 (cg-RX-API-DMAC7.html)
EP (1) EP4298105A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024507550A (cg-RX-API-DMAC7.html)
WO (1) WO2022182604A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4358968A4 (en) * 2021-06-22 2025-05-07 Rome Therapeutics, Inc. 4-ETHINYL-3-HYDROXY-TETRAHYDROFURANYL ADENINE PHOSPHORAMIDATE AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
WO2002074769A1 (en) 2001-03-19 2002-09-26 Ono Pharmaceutical Co., Ltd. Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient
CA2502109C (en) * 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative
WO2013187978A1 (en) * 2012-06-16 2013-12-19 Nanjing Molecular Research, Inc. Double-liver-targeting phosphoramidate and phosphonoamidate prodrugs
PH12021500034A1 (en) * 2019-03-06 2022-06-06 Glaxosmithkline Ip No 2 Ltd Compounds useful in hiv therapy
KR102987126B1 (ko) * 2020-03-20 2026-07-07 길리애드 사이언시즈, 인코포레이티드 4'-c-치환된-2-할로-2'-데옥시아데노신 뉴클레오시드의 프로드러그 및 이의 제조 및 사용 방법

Similar Documents

Publication Publication Date Title
JP2024001048A5 (cg-RX-API-DMAC7.html)
JP3133345B2 (ja) Hivに対して活性な連結環状ポリアミン
JP2024508755A5 (cg-RX-API-DMAC7.html)
JP2024050527A5 (cg-RX-API-DMAC7.html)
JP2024543982A5 (cg-RX-API-DMAC7.html)
JP2023531311A5 (cg-RX-API-DMAC7.html)
JP2022545359A5 (cg-RX-API-DMAC7.html)
JP2020169171A5 (cg-RX-API-DMAC7.html)
JP2022547558A5 (cg-RX-API-DMAC7.html)
JP2022505841A5 (cg-RX-API-DMAC7.html)
JP2020534263A5 (cg-RX-API-DMAC7.html)
JP2011509309A5 (cg-RX-API-DMAC7.html)
JP2020533352A5 (cg-RX-API-DMAC7.html)
JPH07108855B2 (ja) 循環器治療薬として有用な酸化窒素―第一級アミン安定化コンプレックス
JP2022505597A5 (cg-RX-API-DMAC7.html)
JP2001526269A5 (cg-RX-API-DMAC7.html)
JP2011509302A5 (cg-RX-API-DMAC7.html)
JP2011509301A5 (cg-RX-API-DMAC7.html)
JP2022505989A5 (cg-RX-API-DMAC7.html)
JP2022525013A5 (cg-RX-API-DMAC7.html)
JP2023541203A5 (cg-RX-API-DMAC7.html)
JP2020111571A5 (cg-RX-API-DMAC7.html)
JP2002537258A5 (cg-RX-API-DMAC7.html)
JP2024503723A5 (cg-RX-API-DMAC7.html)
JP2007529426A5 (cg-RX-API-DMAC7.html)